DHNP Hydroxyurea 500mg

Manufacturer
Dae Han New Pharm Co., Ltd.(KOREA,SOUTH)

Registraction Number
MAL20040573AZ

CONTENT: 
500mg hydroxyurea

Indications:

DHNP Hydroxyurea 500mg is indicated for the treatment of:

• Chronic myelogenous leukaemia (CML)

• Cervical cancer

• Sickle cell disease to reduce the frequency of painful episodes and the need for blood transfusions

• Other cancers as determined by a healthcare professional.